Mirum Pharmaceuticals, Inc. SEC filings MIRM
Mirum Pharmaceuticals, Inc. has 674 filings in SEC EDGAR's recent list, going back to Nov 20, 2018. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| D | Filing | Jan 29, 2026 | — |
| NT 10-K | Filing | Feb 28, 2024 | Dec 31, 2023 |
| EFFECT | Filing | Jun 9, 2022 | — |
| CORRESP | Letter to the SEC | Jun 6, 2022 | — |
| UPLOAD | Letter from the SEC | Jun 3, 2022 | — |
| D | Filing | Dec 30, 2020 | — |
| EFFECT | Filing | Aug 12, 2020 | — |
| UPLOAD | Letter from the SEC | Aug 7, 2020 | — |
| EFFECT | Filing | Jan 8, 2020 | — |
| CORRESP | Letter to the SEC | Jan 6, 2020 | — |
| CORRESP | Letter to the SEC | Jan 6, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 30, 2019 | — |
| DRS | Filing | Dec 27, 2019 | — |
| EFFECT | Filing | Jul 17, 2019 | — |
| CERT | 8a cert | Jul 16, 2019 | — |
| CORRESP | Letter to the SEC | Jul 15, 2019 | — |
| CORRESP | Letter to the SEC | Jul 15, 2019 | — |
| 8-A12B | Filing | Jul 15, 2019 | — |
| CORRESP | Letter to the SEC | Jul 12, 2019 | — |
| SEC STAFF LETTER | Filing | Jul 10, 2019 | — |
| UPLOAD | Letter from the SEC | Jul 10, 2019 | — |
| CORRESP | Letter to the SEC | Jul 8, 2019 | — |
| UPLOAD | Letter from the SEC | Jun 28, 2019 | — |
| CORRESP | Letter to the SEC | Jun 27, 2019 | — |
| CORRESP | Letter to the SEC | Jun 21, 2019 | — |
| UPLOAD | Letter from the SEC | Jun 7, 2019 | — |
| DRSLTR | Filing | May 24, 2019 | — |
| DRS/A | Filing | May 24, 2019 | — |
| UPLOAD | Letter from the SEC | May 16, 2019 | — |
| SEC STAFF LETTER | Filing | May 7, 2019 | — |
| DRS | Filing | Apr 18, 2019 | — |
| D | Filing | Nov 20, 2018 | — |
Showing 32 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MIRM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Foster City, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1759425
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.